Celldex Therapeutics, Inc. and CuraGen Corporation Stockholders Approve Acquisition of CuraGen Corporation

NEEDHAM, Mass. & BRANFORD, Conn.--(BUSINESS WIRE)--Celldex Therapeutics, Inc. (Nasdaq: CLDX) and CuraGen Corporation (Nasdaq: CRGN) announced that, at special meetings held earlier today, Celldex's stockholders approved the issuance of shares of Celldex common stock pursuant to the previously disclosed Agreement and Plan of Merger, dated as of May 28, 2009, by and among Celldex, Cottrell Merger Sub, Inc. and CuraGen, and that CuraGen's stockholders approved the Agreement and Plan of Merger.

Back to news